Lineage Cell Therapeutics (LCTX) had the best year between September 1, 1995 and September 30, 1995 by a US stock in 1995, returning 92.8%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Lineage Cell Therapeutics (LCTX) | 1995 | 92.85% |
Trio-Tech International (TRT) | 1995 | 85.19% |
NVE (NVEC) | 1995 | 80% |
Gulf Resources (GURE) | 1995 | 74.63% |
Clearfield (CLFD) | 1995 | 62.16% |
Heritage Global (HGBL) | 1995 | 53.13% |
Bausch Health Companies (BHC) | 1995 | 50.82% |
Soligenix (SNGX) | 1995 | 50% |
Electro-Sensors (ELSE) | 1995 | 46.67% |
Imunon (IMNN) | 1995 | 44.44% |
LSI Industries (LYTS) | 1995 | 44.15% |
Forward Industries (FORD) | 1995 | 43.75% |
STERIS (STE) | 1995 | 42.8% |
ClearOne (CLRO) | 1995 | 38.89% |
Portage Biotech (PRTG) | 1995 | 38.67% |
Hologic (HOLX) | 1995 | 38.35% |
Champions Oncology (CSBR) | 1995 | 37.5% |
DLH (DLHC) | 1995 | 35.85% |
RF Industries (RFIL) | 1995 | 34.99% |
Movado (MOV) | 1995 | 31.81% |
Taylor Devices (TAYD) | 1995 | 31.25% |
Ultralife (ULBI) | 1995 | 30.67% |
Consolidated Water (CWCO) | 1995 | 30% |
CEL-SCI (CVM) | 1995 | 29.82% |
SunOpta (STKL) | 1995 | 29.63% |
